← Back to Search

Assist MH Digital Technologies to Support School Mental Health Care (ASSIST-MH Trial)

N/A

Waitlist Available

Led By Melissa E DeRosier, PhD

Research Sponsored by 3-C Institute for Social Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* must be a SMH provider (providing services to 12- to 17-year-old students) or a student (12 to 17 years old)

* if they are a SMH provider, have their supervisor agree to provide oversight of their use of Assist-MH during the trial period

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 months apart, as pre- and post-test

Awards & highlights

No Placebo-Only Group

Summary

The goal of this SBIR is to develop and test Assist-MH, a new interactive digital support system for SMH providers. Assist-MH will offer an innovative interactive planning tool to help providers create a treatment plan customized to the student's specific needs. Based on inputs, the system will generate both provider-led MH strategies to optimize time spent with the student and self-paced digital strategies (video, game-based, interactive) for students to augment in-person treatment and provide unique between-session learning and practice. SMH providers will use Assist-MH to plan and assign individualized MH strategies as well as monitor student progress over time (completion and MH functioning).

Eligible Conditions

Therapy
School counseling
Text Neck
Carpal Tunnel Syndrome

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 months apart, as pre- and post-test

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 months apart, as pre- and post-test

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months apart, as pre- and post-test for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Focus group prototype evaluation

Pilot prototype evaluation

Secondary study objectives

Comfort & Skills survey

Emotional Exhaustion subscale

GAD-7 (Generalized Anxiety Disorder)

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: ASSIST-MHExperimental Treatment1 Intervention

Participants in the focus group will all be given the same set of study tasks. They will participate in a 60-minute virtual focus group and then rate the proposed Assist-MH product components. Participants in the pilot test will complete the same study tasks as others in their respective group: one group for providers and one group for students. All providers will (a) attend a brief webinar to review research methods and be trained to use Assist-MH, (b) use Assist-MH over a 2-month period with at least 3 students, (c) obtain parent consent for students to use Assist-MH and evaluate their experience, (d) complete pre \& post provider outcomes measures, and (e) rate their experiences with the prototype. All students will (a) use Assist-MH, (b) complete pre \& post student outcomes measures, and (c) rate their experiences with the prototype.

0 / 5Eligibility criteria met